Baylor College of Medicine enrolling participants in COVID-19 treatment trial
The study will evaluate the safety and effectiveness of novel therapeutic agents, the first which is the experimental antiviral drug remdesivir.
Building "Bridges" Across the Bayou City!
The study will evaluate the safety and effectiveness of novel therapeutic agents, the first which is the experimental antiviral drug remdesivir.